Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Roe

Showing results (1-10 of 467) with videos related to

Pageof 47
Sort By:
Clinical Trials (London, England)|July 17, 2020
Leveraging electronic health record data for pragmatic randomized trialsMatthew T Roe
American Heart Journal|October 30, 2004
Success stories: how hospitals are improving careMatthew T Roe
The New England Journal of Medicine|August 13, 2015
Cardiac Troponin and Risk Stratification in Ischemic Heart DiseaseChiara Melloni, Matthew T Roe
Circulation|October 29, 2019
Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular DiseaseMatthew T Roe, John Strickler
Urologic Oncology|March 19, 2019
Androgen deprivation therapy and cardiovascular diseaseChiara Melloni, Matthew T Roe
Cardiovascular Drug Reviews|July 7, 2007
Optimizing platelet P2Y12 inhibition for patients undergoing PCISteven Steinhubl, Matthew T Roe
Drug Safety|April 2, 2015
Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary interventionJoakim Alfredsson, Matthew T Roe
Nature Reviews. Cardiology|June 25, 2014
Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remainTariq Ahmad, Matthew T Roe
Journal of the American Heart Association|March 21, 2015
Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implicationsJoakim Alfredsson, Matthew T Roe
Journal of the American College of Cardiology|September 14, 2019
Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary SyndromesMatthew T Roe, Guillaume Marquis-Gravel
Pageof 47

Showing results (1-10 of 467) with videos related to

Sort By:
Pageof 47
Clinical Trials (London, England)|July 17, 2020
Leveraging electronic health record data for pragmatic randomized trialsMatthew T Roe
American Heart Journal|October 30, 2004
Success stories: how hospitals are improving careMatthew T Roe
The New England Journal of Medicine|August 13, 2015
Cardiac Troponin and Risk Stratification in Ischemic Heart DiseaseChiara Melloni, Matthew T Roe
Circulation|October 29, 2019
Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular DiseaseMatthew T Roe, John Strickler
Urologic Oncology|March 19, 2019
Androgen deprivation therapy and cardiovascular diseaseChiara Melloni, Matthew T Roe
Cardiovascular Drug Reviews|July 7, 2007
Optimizing platelet P2Y12 inhibition for patients undergoing PCISteven Steinhubl, Matthew T Roe
Drug Safety|April 2, 2015
Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary interventionJoakim Alfredsson, Matthew T Roe
Nature Reviews. Cardiology|June 25, 2014
Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remainTariq Ahmad, Matthew T Roe
Journal of the American Heart Association|March 21, 2015
Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implicationsJoakim Alfredsson, Matthew T Roe
Journal of the American College of Cardiology|September 14, 2019
Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary SyndromesMatthew T Roe, Guillaume Marquis-Gravel
Pageof 47